Belhaven Biopharma Inc. has filed a notice of an exempt offering of securities to raise $32,289,627.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Belhaven Biopharma Inc. is raising up to $32,289,627.00 in new funding. The federal securities law requires the notice to be filed by companies that have…